title: Effects of commonly used mitogens on the cytotoxicity of 4-tertiary butylphenol to human melanocytes.
abstract: In the search for environmental compounds responsible for contact or occupational vitiligo, it was found that the most potent was 4-tertiary butylphenol (4-TBP). Exposure to 4-TBP is widespread both in industry and in consumer items including synthetic leather, plastic, glues, and germicidal phenolic detergents. How 4-TBP causes depigmentation and the death of melanocytes is currently unclear. Growth mitogens for human melanocytes include alpha-melanocyte stimulating hormone (alpha-MSH), basic fibroblast growth factor (bFGF) and 12-o-tetradecanoylphorbol-13-acetate (TPA). The former two mitogens are physiological growth factors for melanocytes. We have studied the effects of these mitogens on the cytotoxicity of 4-TBP in human melanocytes. Our results demonstrated that deprivation of alpha-MSH or bFGF from melanocyte cultures resulted in reduced cytotoxicity to 4-TBP. Similar results were obtained upon treatment of melanocytes with an inhibitor of cAMP-dependent protein kinase A (PKA), that is known to be activated by alpha-MSH, or with an inhibitor of the tyrosine kinase bFGF receptor. In contrast, removal of fetal bovine serum or TPA from the culture medium did not influence the susceptibility of melanocytes to 4-TBP. These results suggest that activation of the cAMP and tyrosine kinase signaling pathways, both of which are involved in the mitogenic response of melanocytes, increase the susceptibility of these cells to the cytotoxic effects of 4-TBP.
authors.affiliation: Department of Dermatology, University of Cincinnati College of Medicine, Ohio 45267, USA.
authors.forename: F
authors.initials: F
authors.lastname: Yang
authors.forename: Z
authors.initials: Z
authors.lastname: Abdel-Malek
authors.forename: R E
authors.initials: RE
authors.lastname: Boissy
mesh_terms: D000818:Animals; D001769:Blood; D002417:Cattle; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000502:physiology; D006801:Humans; D008544:Melanocytes / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D008934:Mitogens / Q000494:pharmacology*; D010636:Phenols / Q000633:toxicity*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D000521:alpha-MSH / Q000494:pharmacology
chemical_list: D008934:Mitogens; D010636:Phenols; D016222:Fibroblast Growth Factor 2; D000521:alpha-MSH; D000242:Cyclic AMP; D017868:Cyclic AMP-Dependent Protein Kinases; D013755:Tetradecanoylphorbol Acetate; C006862:butylphen